...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Name Confusion

Response back :

"....... we are aware of the situation with TD and we continue to peruse getting this rectified"

Share
New Message
Please login to post a reply